Healthcare systems worldwide grapple with pharmaceutical costs & emerging technologies 📲
#LSEHealth brings together international experts to explore how HTA approaches serve patients & society.🔍
Join the #PharmaceuticalPolicyLab on 10 Dec!
Register:👉 bit.ly/4qWlBKt
#LSEHealth brings together international experts to explore how HTA approaches serve patients & society.🔍
Join the #PharmaceuticalPolicyLab on 10 Dec!
Register:👉 bit.ly/4qWlBKt
November 25, 2025 at 10:02 AM
Healthcare systems worldwide grapple with pharmaceutical costs & emerging technologies 📲
#LSEHealth brings together international experts to explore how HTA approaches serve patients & society.🔍
Join the #PharmaceuticalPolicyLab on 10 Dec!
Register:👉 bit.ly/4qWlBKt
#LSEHealth brings together international experts to explore how HTA approaches serve patients & society.🔍
Join the #PharmaceuticalPolicyLab on 10 Dec!
Register:👉 bit.ly/4qWlBKt
#NICE #MHRANICEpathway #MHRA #reimbursement #NHS #HuseyinNaci #LSE #BMJ #HealthPolicy #PharmaceuticalPolicyLab #drugevaluations #NICEcommittees #NHSresources #USUKtradeagreement #NICEcosteffectivenessthreshold #ABPI #health #lifesciences #patientaccess #medicines #HEOR #pharmanews
zurl.co/ZOSKm
zurl.co/ZOSKm
Joint MHRA/NICE pathway 'benefits industry over patients'
LSE pharma policy expert contends the MHRA/NICE aligned pathway is weighted towards industry, and calls for an assessment of its impact on the NHS.
pharmaphorum.com
May 15, 2026 at 10:56 AM